Also found in: Thesaurus, Medical, Wikipedia.


A trademark for the drug infliximab.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Remicade - a monoclonal antibody (trade name Remicade) used to treat Crohn's disease and rheumatoid arthritis; administered by infusion; use and dosage must be determined by a physician
monoclonal, monoclonal antibody - any of a class of antibodies produced in the laboratory by a single clone of cells or a cell line and consisting of identical antibody molecules
2.Remicade - an anti-TNF compound (trade name Remicade) consisting of an antibody directed against TNF; it is given intravenously at one-month to three-month intervals; used in treatment of regional enteritis and rheumatoid arthritis
anti-TNF compound - a class of drugs that block the action of tumor necrosis factor (TNF); used in cases of rheumatoid arthritis because TNF instigates inflammation of the joints
brand, brand name, marque, trade name - a name given to a product or service
References in periodicals archive ?
Janssen Biotech, a company of Johnson & Johnson, owns the patent, which relates to the company's arthritis drug Remicade.
NYSE: PFE), with South Korea-based biopharmaceutical company Celltrion Healthcare, has released secondary outcomes data from the phase III trial of Inflectra in Crohn's Disease (CD) that show that switching patients with CD to Inflectra (infliximab CT-P13) from Remicade (infliximab) led to comparable efficacy, safety, and tolerability to treatment with Remicade over a 24 week period, the company said.
Like Remicade, Renflexis will come with a boxed warning and a Medication Guide that describes important information about its uses and risks, which include serious infections, lymphoma and other malignancies, liver injury, blood problems, lupuslike syndrome, psoriasis, and in rare cases, nervous system disorders.
It was reported yesterday that the statement of objections is for the Competition and Markets Authority's provisional decision that the company operated an anti-competitive discount scheme for its medicine, Remicade.
The Competition and Markets Authority (CMA) said MSD appears to have abused its marketleading position by discounting the rheumatoid arthritis medicine Remicade to such an extent that it is holding back competition from similar versions sold by other firms.
s lower-price alternative to autoimmune disease drug Remicade doesn't infringe a Johnson & Johnson (J&J) patent on the blockbuster drug.
NHS England has decided not to recommend routine use of drugs Humira and Remicade for patients with the severe eye condition.
The approval of revolutionary biological therapies, including Enbrel, Remicade and Humira, for the treatment of RA patients that are refractory to MTX has triggered unparalleled growth in the market.
J&J's Remicade, has gained a significant patent share of the aGVI ID patient group, as it is one of the few drugs that are efficient in GVHD with G1 involvement.
At issue is whether Merck's $41 billion acquisition of Schering-Plough last year constituted a "change of control" at Schering that would cede the lucrative overseas Remicade and Simponi rights back to J&J, which owns the drugs and sells them in the United States.
Horsham, PA) and Schering-Plough Corporation (Kenilworth, NJ) have revised their 1998 distribution agreement regarding the development, commercialization and distribution of both REMICADE (infliximab), an anti-tumor necrosis factor (anti-TNF) alpha therapy for chronic inflammatory disorders, and golimumab, Centocor's next-generation, human, anti-TNF alpha therapy, which is currently in Phase 3 trials.